UCSF Start-Up Shows Off Its Approach To K-Ras Inhibition

In February, Janssen Biotech announced a collaboration with Araxes, a start-up out of the University of California, San Francisco. Now, with a publication in Nature, further details on the company have been revealed.

More from R&D

More from Scrip